Nuclear-translocated endostatin downregulates hypoxia inducible factor-1α activation through interfering with Zn(II) homeostasis

Guo,Lifang; Chen,Yang; He,Ting; Qi,Feifei; Liu,Guanghua; Fu,Yan; Rao,Chunming; Wang,Junzhi; Luo,Yongzhang

doi:10.3892/mmr.2015.3223

May-2015 Volume 11 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-2015 Volume 11 Issue 5

Full Size Image

Article

Nuclear-translocated endostatin downregulates hypoxia inducible factor-1α activation through interfering with Zn(II) homeostasis

Authors:
- Lifang Guo
- Yang Chen
- Ting He
- Feifei Qi
- Guanghua Liu
- Yan Fu
- Chunming Rao
- Junzhi Wang
- Yongzhang Luo
View Affiliations / Copyright

Affiliations: School of Life Sciences, Lanzhou University, Lanzhou, Gansu 730000, P.R. China, National Engineering Laboratory for Anti‑Tumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China, National Institutes for Food and Drug Control, Beijing 100050, P.R. China
Pages: 3473-3480
|
Published online on: January 19, 2015

https://doi.org/10.3892/mmr.2015.3223
Expand metrics +

Abstract

Hypoxia‑inducible factor‑1α (HIF‑1α) is key in tumor progression and aggressiveness as it regulates a series of genes involved in angiogenesis and anaerobic metabolism. Previous studies have shown that the transcriptional levels of HIF‑1α may be downregulated by endostatin. However, the molecular mechanism by which endostatin represses HIF‑1α expression remains unknown. The current study investigated the mechanism by which nuclear‑translocated endostatin suppresses HIF‑1α activation by disrupting Zn(II) homeostasis. Endostatin was observed to downregulate HIF‑1α expression at mRNA and protein levels. Blockage of endostatin nuclear translocation by RNA interference of importin α1/β1 or ectopic expression of NLS‑deficient mutant nucleolin in human umbilical vein endothelial cells co‑transfected with small interfering (si)‑nucleolin siRNA compromises endostatin‑reduced HIF‑1α expression. Nuclear‑translocated apo‑endostatin, but not holo‑endostatin, significantly disrupts the interaction between CBP/p300 and HIF‑1α by disturbing Zn(II) homeostasis, which leads to the transcriptional inactivation of HIF‑1α. The results reveal mechanistic insights into the method by which nuclear‑translocated endostatin downregulates HIF‑1α activation and provides a novel way to investigate the function of endostatin in endothelial cells.

View Figures

View References

1	Ke Q and Costa M: Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 70:1469–1480. 2006. View Article : Google Scholar : PubMed/NCBI
2	Leung KW, Ng HM, Tang MK, Wong CC, Wong RN and Wong AS: Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis. Angiogenesis. 14:515–522. 2011. View Article : Google Scholar : PubMed/NCBI
3	Liao D, Corle C, Seagroves TN and Johnson RS: Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res. 67:563–572. 2007. View Article : Google Scholar : PubMed/NCBI
4	Frolova O, Samudio I, Benito JM, et al: Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment. Cancer Biol Ther. 13:858–870. 2012. View Article : Google Scholar : PubMed/NCBI
5	Ryan HE, Lo J and Johnson RS: HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005–3015. 1998. View Article : Google Scholar : PubMed/NCBI
6	Onnis B, Rapisarda A and Melillo G: Development of HIF-1 inhibitors for cancer therapy. J Cell Mol Med. 13:2780–2786. 2009. View Article : Google Scholar : PubMed/NCBI
7	Sapra P, Kraft P, Pastorino F, et al: Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects. Angiogenesis. 14:245–253. 2011. View Article : Google Scholar : PubMed/NCBI
8	Abdollahi A, Hahnfeldt P, Maercker C, et al: Endostatin’s antiangiogenic signaling network. Mol Cell. 13:649–663. 2004. View Article : Google Scholar : PubMed/NCBI
9	O’Reilly MS, Boehm T, Shing Y, et al: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:277–285. 1997. View Article : Google Scholar
10	Abdollahi A, Hlatky L and Huber PE: Endostatin: the logic of antiangiogenic therapy. Drug Resist Updat. 8:59–74. 2005. View Article : Google Scholar : PubMed/NCBI
11	MacDonald NJ, Shivers WY, Narum DL, et al: Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin. J Biol Chem. 276:25190–25196. 2001. View Article : Google Scholar : PubMed/NCBI
12	Karumanchi SA, Jha V, Ramchandran R, et al: Cell surface glypicans are low-affinity endostatin receptors. Mol Cell. 7:811–822. 2001. View Article : Google Scholar : PubMed/NCBI
13	Shi H, Huang Y, Zhou H, et al: Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood. 110:2899–2906. 2007. View Article : Google Scholar : PubMed/NCBI
14	Chen Y, Wang S, Lu X, Zhang H, Fu Y and Luo Y: Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. Blood. 117:6392–6403. 2011. View Article : Google Scholar : PubMed/NCBI
15	Song N, Ding Y, Zhuo W, et al: The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells. Angiogenesis. 15:697–711. 2012. View Article : Google Scholar : PubMed/NCBI
16	Han Q, Fu Y, Zhou H, He Y and Luo Y: Contributions of Zn(II)-binding to the structural stability of endostatin. FEBS Lett. 581:3027–3032. 2007. View Article : Google Scholar : PubMed/NCBI
17	Song N, Huang Y, Shi H, et al: Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis. Cancer Res. 69:6057–6064. 2009. View Article : Google Scholar : PubMed/NCBI
18	Toffoli S, Roegiers A, Feron O, et al: Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1. Angiogenesis. 12:47–67. 2009. View Article : Google Scholar : PubMed/NCBI
19	Calvani M, Rapisarda A, Uranchimeg B, Shoemaker RH and Melillo G: Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood. 107:2705–2712. 2006. View Article : Google Scholar
20	Chen MC, Lee CF, Huang WH and Chou TC: Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Biochem Pharmacol. 85:1278–1287. 2013. View Article : Google Scholar : PubMed/NCBI
21	Ding YH, Javaherian K, Lo KM, et al: Zinc-dependent dimers observed in crystals of human endostatin. Proc Natl Acad Sci USA. 95:10443–10448. 1998. View Article : Google Scholar : PubMed/NCBI
22	Fu Y and Luo Y: The N-terminal integrity is critical for the stability and biological functions of endostatin. Biochemistry. 49:6420–6429. 2010. View Article : Google Scholar : PubMed/NCBI
23	Nyborg JK and Peersen OB: That zincing feeling: the effects of EDTA on the behaviour of zinc-binding transcriptional regulators. Biochem J. 381:e3–e4. 2004. View Article : Google Scholar : PubMed/NCBI
24	Fu Y, Tang H, Huang Y, Song N and Luo Y: Unraveling the mysteries of endostatin. IUBMB Life. 61:613–626. 2009. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Nuclear-translocated endostatin downregulates hypoxia inducible factor-1α activation through interfering with Zn(II) homeostasis

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Related Articles